Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Department of Biostatistics and Bioinformatics, Duke Clinical Research Institute, Durham, North Carolina.
JAMA Intern Med. 2020 Apr 1;180(4):494-502. doi: 10.1001/jamainternmed.2019.6958.
Patients with abnormal (positive) exercise electrocardiography, but normal stress echocardiography (+ECG/-Echo) are commonly encountered in clinical practice; however, the prognostic significance of this discordant result is unclear.
To determine whether patients with +ECG/-Echo have a higher rate of adverse clinical events and a poorer prognosis than patients with negative exercise ECG and normal stress Echo imaging (-ECG/-Echo).
DESIGN, SETTING, AND PARTICIPANTS: Between January 1, 2000, and February 28, 2014, a total of 47 944 consecutive patients without known coronary artery disease who underwent exercise stress Echo at Duke University Medical Center were evaluated for inclusion in this observational cohort study. Data analysis was conducted from January 1, 2000, to December 31, 2016.
INTERVENTIONS/EXPOSURES: Patients were categorized as having -ECG/-Echo, +ECG/-Echo, or +Echo (-ECG/+Echo and +ECG/+Echo).
The primary outcome was a composite end point of death, myocardial infarction, hospitalization for unstable angina, and coronary revascularization. Secondary outcomes included individual adverse events and downstream testing.
After excluding submaximal tests and nondiagnostic ECG or stress imaging results, 15 077 patients (mean [SD] age, 52 [13] years; 6228 [41.3%] men) were classified by stress test results. Of these, 12 893 patients (85.5%) had -ECG/-Echo, 1286 patients (8.5%) had +ECG/-Echo, and 898 patients (6.0%) had +Echo. Through a median follow-up of 7.3 (interquartile range, 4.4-10.0) years, the composite end point occurred in 794 patients with -ECG/-Echo (8.5%), 142 patients with +ECG/-Echo (14.6%), and 297 patients with +Echo (37.4%). Death occurred in 425 patients with -ECG/-Echo (4.8%), 50 patients with +ECG/-Echo (5.9%), and 70 patients with +Echo (11.2%). Myocardial infarction occurred in 195 patients with -ECG/-Echo (2.2%), 31 patients with +ECG/-Echo (3.6%), and 59 patients with +Echo (8.7%). The addition of stress ECG findings to clinical and exercise data yielded incremental prognostic value. Patients with -ECG/-Echo imaging results had the least downstream testing (2.3%), followed by +ECG/-Echo (12.8%), and +Echo (33.6%) (P < .001).
The presence of +ECG results with normal stress Echo imaging may identify a population of patients who are at slightly increased risk for adverse cardiac events, which was not previously recognized. Further study is needed to determine whether these patients will benefit from intensification of medical management.
临床上常遇到运动心电图异常(阳性)但负荷超声心动图正常(+ECG/-Echo)的患者;然而,这种不一致结果的预后意义尚不清楚。
确定与运动心电图阴性和正常负荷超声心动图成像(-ECG/-Echo)的患者相比,+ECG/-Echo 的患者是否具有更高的不良临床事件发生率和更差的预后。
设计、地点和参与者:2000 年 1 月 1 日至 2014 年 2 月 28 日期间,共纳入了 47944 名在杜克大学医疗中心接受运动负荷超声心动图检查且无已知冠状动脉疾病的连续患者,进行了这项观察性队列研究。数据分析于 2000 年 1 月 1 日至 2016 年 12 月 31 日进行。
干预/暴露:患者分为 -ECG/-Echo、+ECG/-Echo 或 +Echo(-ECG/+Echo 和 +ECG/+Echo)。
主要结局是死亡、心肌梗死、不稳定型心绞痛住院和冠状动脉血运重建的复合终点。次要结局包括个别不良事件和下游检查。
排除次最大试验和非诊断性心电图或压力成像结果后,根据压力测试结果对 15077 名患者(平均[标准差]年龄,52[13]岁;6228[41.3%]男性)进行了分类。其中,12893 名患者(85.5%)为 -ECG/-Echo,1286 名患者(8.5%)为 +ECG/-Echo,898 名患者(6.0%)为 +Echo。通过中位数为 7.3 年(四分位距,4.4-10.0)的随访,-ECG/-Echo 的患者中有 794 人(8.5%)发生复合终点,+ECG/-Echo 的患者中有 142 人(14.6%),+Echo 的患者中有 297 人(37.4%)。-ECG/-Echo 的患者中有 425 人(4.8%)死亡,+ECG/-Echo 的患者中有 50 人(5.9%),+Echo 的患者中有 70 人(11.2%)。-ECG/-Echo 的患者中有 195 人(2.2%)发生心肌梗死,+ECG/-Echo 的患者中有 31 人(3.6%),+Echo 的患者中有 59 人(8.7%)。压力心电图检查结果的加入增加了临床和运动数据的预后价值。-ECG/-Echo 成像结果的患者进行的下游检查最少(2.3%),其次是+ECG/-Echo(12.8%)和+Echo(33.6%)(P<0.001)。
正常负荷超声心动图结果阳性的心电图结果可能会识别出风险略有增加的不良心脏事件的患者群体,这是以前未被认识到的。需要进一步研究以确定这些患者是否会从强化医疗管理中获益。